Publications
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex (R)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.2010 | Central Library of Charles University
- Cognitive rehabilitation in patients with multiple sclerosis2014 | Faculty of Medicine in Pilsen
- Paraneoplastic neurological syndromes – essential characteristics, classification, etiopathogenesis and diagnostics2013 | Faculty of Medicine in Pilsen
- Paraneoplastic syndromes of peripheral nerves, neuromuscular junction and muscles2013 | Faculty of Medicine in Pilsen
- Peripheral neuropathy and hepatitis C2013 | Faculty of Medicine in Pilsen
- Paraneoplastic disorders – introduction2013 | Faculty of Medicine in Pilsen
- First line therapy in CIDP. Corticosteroids or IVIG? Corticosteroids as first line therapy in CIDP.2013 | Faculty of Medicine in Pilsen
- Peripheral neuropathy in malignancies2013 | Faculty of Medicine in Pilsen
- Statins and myopathy2013 | Faculty of Medicine in Pilsen
Loading network view...